ArticleJournal for immunotherapy of cancer2025

In situ DC-primed vaccine combined with CD137 agonist elicits long-lasting antitumor immunity through cDC1-mediated tumor antigen-specific CD8

Mengjiao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.